Bempedoic acid
Esperion
['cardio']
 clear outcomes trial just presented #acc23 in 13,970 statin-intolerant patients, #bempedoic acid significantly reduced the risk of the primary mace-4 endpoint by 13% results now published #cardiotwitter #medtwitter 
🇮🇹 🇪🇺 MD | PhD | Assistant Professor and Cardiologist at @unicampania | @ESC_Journals | #EHJPharmacotherapy Twitter Editor 💊